| 2D Structure | |
| CID | 91513 |
| IUPAC Name | 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;dihydrochloride |
| InChI | InChI=1S/C21H27ClN2O2.2ClH/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25;;/h1-9,21,25H,10-17H2;2*1H |
| InChI Key | ANOMHKZSQFYSBR-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C21H29Cl3N2O2 |
| Molecular Weight | 447.8 |
| synonyms | ['Hydroxyzine dihydrochloride', '2192-20-3', 'Hydroxyzine hydrochloride', 'Orgatrax', 'Hydroxyzine Hcl', 'Atranine A', 'Atarax dihydrochloride', 'HYDROXIZINE CHLORIDE', 'DTXSID2040737', '76755771U3', '2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol dihydrochloride', 'Ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)-, dihydrochloride', 'CHEBI:5819', 'DTXCID3027530', 'Anxanil', 'Ucerax', 'Hyzine-50', '1-(p-Chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)diethylenediamine hydrochloride', 'RefChem:789578', 'DTXCID0020737', '2-(2-(4-((RS)-(4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol dihydrochloride', '218-586-3', 'DTXSID5047530', '2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol dihydrochloride', 'Alamon', 'Hydroxyzine 2HCl', 'Atarax', 'MFCD00058200', 'Durrax', 'Hydroxyzine DiHCl', 'C21H29Cl3N2O2', 'Hydroxyzine (dihydrochloride)', '2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;dihydrochloride', 'Hydroxyzine.2HCl', 'Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-,dihydrochloride', '163837-38-5', 'Hydroxyzine D4 dihydrochloride', 'Arcanax', 'Neurolax', 'Vistaject', 'Vistarex', 'Disron', 'Quiess', 'Vistaril steraject', 'Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride', 'Vistaril Parenteral', 'QYS', 'Tran-Q dihydrochloride', '5AQ4KXB9U4', 'GF8H55RPZ9', 'Ataraxoid dihydrochloride', 'Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, hydrochloride (1:2)', 'Tranquizine dihydrochloride', 'Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, dihydrochloride', 'Vistaril (TN)', 'Prestwick_272', 'EINECS 218-586-3', 'Atarax (TN)', '2-[2-[4-[(4-Chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]ethanol dihydrochloride', 'AI3-50162', '2192-20-3 (2HCl)', 'UNII-5AQ4KXB9U4', 'UNII-GF8H55RPZ9', 'Hydroxyzine hydrochloride CRS', 'SCHEMBL491323', 'HY-B0548AR', 'orb1306126', 'orb3025463', 'CHEMBL3186993', 'HY-B0548A', 'GLXC-07793', 'HMS1568K08', 'HMS5082D19', 'Hydroxyzine dihydrochloride, (+)-', 'Hydroxyzine dihydrochloride, (-)-', 'Hydroxyzine dihydrochloride, >=98%', 'EBC-13167', 'Hydroxyzine hydrochloride [USP:JAN]', 'MSK001095', 's4026', 'UNII-76755771U3', 'AKOS015846478', 'Hydroxyzine hydrochloride (JP18/USP)', 'AC-8086', 'CCG-220133', 'FH24516', 'HS-0097', 'HYDROXYZINE HYDROCHLORIDE [JAN]', '(+-)-2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol dihydrochloride', '2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol dihydrochloride', 'Dichlorhydrate de 1-p.chlorbenzhydryl-4-(2-(2-hydroxyethoxy)ethyl)piperazine [French]', 'HYDROXYZINE DIHYDROCHLORIDE [MI]', 'Hydroxyzine (dihydrochloride) (Standard)', 'HYDROXYZINE HYDROCHLORIDE [MART.]', 'HYDROXYZINE HYDROCHLORIDE [VANDF]', 'NCGC00089816-02', 'Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)-', 'HYDROXYZINE HYDROCHLORIDE [USP-RS]', 'HYDROXYZINE HYDROCHLORIDE [WHO-DD]', 'SY066724', 'NS00076231', 'SW196577-3', 'VU0239818-5', 'D00672', 'HYDROXYZINE HYDROCHLORIDE [EP MONOGRAPH]', 'HYDROXYZINE HYDROCHLORIDE [ORANGE BOOK]', 'O10449', 'HYDROXYZINE HYDROCHLORIDE [USP MONOGRAPH]', 'SR-01000003137', 'SR-01000003137-2', 'Hydroxyzine.2HCl, 1mg/ml in Methanol (as free base)', 'Q27106898', 'Z2680630178', 'Hydroxyzine Hydrochloride 1.0 mg/ml in Methanol (as free base)', 'Hydroxyzine hydrochloride, European Pharmacopoeia (EP) Reference Standard', '1-(P-CHLOROBENZHYDRYL)-4-(2-(2-HYDROXYETHOXY)ETHYL)DIETHYLENEDIAMINE DIHYDROCHLORIDE', '2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethan-1-ol dihydrochloride', '2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol 2HCl', '2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanoldihydrochloride', '2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol;dihydrochloride', 'Dichlorhydrate de 1-p.chlorbenzhydryl-4-(2-(2-hydroxyethoxy)ethyl)piperazine', 'Hydroxyzine Dihydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material', 'Hydroxyzine hydrochloride, United States Pharmacopeia (USP) Reference Standard', '(+/-)-2-(2-(4-(P-CHLORO-.ALPHA.-PHENYLBENZYL)-1-PIPERAZINYL)ETHOXY)ETHANOL DIHYDROCHLORIDE', '163837-37-4', '2-(2-(4-(P-CHLORO-.ALPHA.-PHENYLBENZYL)-1-PIPERAZINYL)ETHOXY)ETHANOL DIHYDROCHLORIDE', '2-(2-{4-[(4-Chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)ethan-1-ol--hydrogen chloride (1/2)', 'Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+)-', 'ETHANOL, 2-(2-(4-((4-CHLOROPHENYL)PHENYLMETHYL)-1-PIPERAZINYL)ETHOXY)-, DIHYDROCHLORIDE, (+/-)-', 'Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (-)-', 'ETHANOL, 2-(2-(4-(P-CHLORO-.ALPHA.-PHENYLBENZYL)-1-PIPERAZINYL)ETHOXY)-, DIHYDROCHLORIDE'] |
From Pubchem